Kit for the Preparation of Indium In 111 Pentetreotide
Diagnostic - For Intravenous Use.
Approved
Approval ID
e2117bbd-9db3-4d20-a5da-89551c18a0cb
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Apr 21, 2025
Manufacturers
FDA
Sun Pharmaceutical Industries, Inc.
DUNS: 037074409
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Indium In-111 Pentetreotide
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code45567-0755
Application NumberANDA212785
Product Classification
M
Marketing Category
C73584
G
Generic Name
Indium In-111 Pentetreotide
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateApril 21, 2025
FDA Product Classification